Cheaper Generic Medication for Lipitor, Actos and Plavix

Generic Versions of Lipitor, Actos and Plavix Might Enter Market

| May 27, 2011

A recent article in the Chicago Tribune reports that patients using Lipitor, Actos, or Plavix may start enjoying savings of up to 90 percent as patents on those drugs expire. The three drugs comprise a significant percentage of the $300 billion brand-name U.S. pharmaceutical market, according to the Tribune.

As patents granting exclusivity to the drugs' manufacturers expire, cheaper generic versions will begin to enter the market. Lipitor, for example, now costs up to $40 for a one-month supply. However, competing generic forms of the cholesterol-lowering drug could drive the cost down as low as $4 per month-a 90 percent savings.

Among the three drugs the article discusses, Actos is the one directed at the diabetes market. Produced by Takeda for people with type 2 diabetes, Actos (pioglitazone) is a thiazolidinedione, which works by increasing the body's sensitivity to insulin. According to Consumer Reports, U.S patients spent $3.5 billion in 2010 for the drug.

Inventions and new drugs win patents so that their originators have time to recoup the costs of  research and development. Once those patents expire, other manufacturers can enter the market with generic versions. Generics can be priced much lower because the new sources of supply do not have to create the products from scratch.

Click Here To View Or Post Comments

Categories: Actos, Diabetes, Diabetes, Generic Medication, Lipitor, Pharmaceutical Market /Products , Plavix, Type 2 Issues


Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • What's on the Horizon with Diabetes Research and Therapy
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Latest
Popular
Top Rated
Print | Email | Share | Comments (2)

You May Also Be Interested In...


Comments

Posted by chanson3633 on 1 June 2011

I think the price for a one-month supply of Lipitor is more like $80-$110. There are some promotional offers that Pfizer is putting out, but the standard price is much higher than $40.00.

Posted by Anonymous on 10 June 2011

Good article, but the most significant part of the story was missing entirely. WHEN are these patents expiring ?!?


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...


Username: Password:
Comment:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.